PT - JOURNAL ARTICLE AU - Yaxk’in Coronado AU - Roberto Navarro AU - Carlos Mosqueda AU - Valeria Valenzuela AU - Juan Pablo Perez AU - Víctor González-Mendoza AU - Mayra de la Torre AU - Jorge Rocha TI - SARS-CoV-2 in wastewater from Mexico City used for irrigation in the Mezquital Valley: quantification and modelling of geographic dispersion AID - 10.1101/2021.06.07.21258522 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.07.21258522 4099 - http://medrxiv.org/content/early/2021/06/12/2021.06.07.21258522.short 4100 - http://medrxiv.org/content/early/2021/06/12/2021.06.07.21258522.full AB - Quantification of SARS-CoV-2 in urban wastewaters has emerged as a cheap, efficient strategy to follow trends of active COVID-19 cases in populations. Moreover, mathematical models have been developed that allow prediction of active cases following the temporal patterns of viral loads in wastewaters. In Mexico, no systematic efforts have been reported in the use of this strategies. In this work, we quantified SARS-CoV-2 in rivers and irrigation canals in the Mezquital Valley, Hidalgo, an agricultural region where wastewater from Mexico City is distributed and used for irrigation. Using quantitative RT-PCR, we detected the virus in 6 out of 8 water samples from rivers, and 5 out of 8 water samples from irrigation canals. Notably, samples showed a general consistent trend of having the highest viral loads in the sites closer to Mexico City, indicating that this is the main source that contributes to detection. Using the data for SARS-CoV-2 concentration in the river samples, we generated a simplified transport model that describes the spatial patterns of dispersion of virus in the river. We suggest that this model can be extrapolated to other wastewater systems that require knowledge of spatial patterns of viral dispersion at a geographic scale. Our work highlights the need for improved practices and policies related to the use of wastewater for irrigation in Mexico and other countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was funded by Conacyt Mexico grant 312014 for Jorge RochaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Does not applyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAdditional data on mathematical model is available in the link provided. https://nbviewer.jupyter.org/github/yaxastro3000/COVID_CIAD_URH/blob/c65ac45af14736023e94eb087aea8d541a7dac68/MODEL_COVID_CIAD_URH.ipynb